Today: 21 May 2026
Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge
7 January 2026
1 min read

Critical Metals stock jumps again as Greenland takeover talk keeps rare-earth traders on edge

New York, Jan 7, 2026, 05:18 EST — Premarket

  • Critical Metals was up about 9% premarket after a 26% jump in the prior session.
  • Traders pointed to renewed U.S. talk of acquiring Greenland, where the company is developing its Tanbreez rare-earths project.
  • Investors are watching U.S. jobs data on Friday and any fresh signals from Washington on Greenland.

Critical Metals Corp shares were up 9.2% in premarket trading on Wednesday at $12.90, after closing up 25.6% in the prior session, as renewed U.S. rhetoric over acquiring Greenland stirred fresh interest in rare-earth names.

The move matters because Critical Metals’ flagship Tanbreez project sits in southern Greenland, and rare earths — a group of metals used in magnets for electric motors, electronics and defence systems — have become a strategic focus as the U.S. tries to diversify supply chains away from China.

It also lands as political risk returns to the Arctic. The White House said President Donald Trump was discussing options to acquire Greenland, including the possible use of the U.S. military, even as Greenland and Denmark have rejected any takeover.

Investors in small, project-stage miners often trade headlines that hint at funding, permitting and offtake — long-term contracts to sell future output — rather than near-term earnings. CEO Tony Sage told Reuters last week the company expects to finalise the remaining 25% of Tanbreez offtake agreements by early 2026 and would be open to a Washington investment: “Would welcome it, even though we didn’t ask for it,” he said. Reuters

The stock on Tuesday traded between $9.82 and $12.00, putting the $12 level back in view for short-term traders, after a steep run over the past year that has left the shares well below their 52-week high but far above their lows.

A U.S. peer, MP Materials, was last indicated around $59.82, up about 2% from its prior close, as investors rotated into parts of the critical-minerals space amid the Greenland headlines.

But the rally carries clear risks. Any shift in Greenland’s status remains highly uncertain, and the White House’s comments have already drawn pushback in Europe; a sharper diplomatic response — or a cooling of U.S. rhetoric — could drain the momentum that has driven the stock in recent sessions.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop